Publications

Researchgate profile: https://www.researchgate.net/profile/Ayman_Oweida

Published Articles – refereed

2022

37. Rutihinda C, Haroun R, Saidi NR, Ordoñez JP, Naasri S, Lévesque D, Boisvert FM, Fortier PH, Belzile M, Fradet L, Tremblay VH, Turgeon GA, Wang CS, Delage P, Rousseau E, Paquette B, Oweida AJ. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy. Cancer Immunology, Immunotherapy. 2022.

35. Bickett TE, Knitz MW, Piper M, Oweida AJ, Gadwa J, Darragh LB, Nguyen D, Bhatia S, Bhuvane S, Phan AV, Corbo S, Pham T, Dent AL, Lenz L, Karam SD. Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC. Molecular Therapy. 2022.

36. Knitz MW, Darragh LB, Bickett TE, Bhatia S, Bukkapatnam S, Gadwa J, Piper M, Corbo S, Nguyen D, Van Court B, Oweida A, Karam SD. Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma. Cancer Immunology, Immunotherapy. 2022.

2021

35. Oweida A, Paquette B. Reconciling two opposing effects of radiation therapy: stimulation of cancer cell invasion and activation of anti-cancer immunity. International Journal of Radiation Biology; 2022.

34. Korpela SP, Hinz TK, Oweida A, Kim J, Calhoun J, Ferris R, Nemenoff RA, Karam SD, Clambey ET, Heasley LE. Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response. Journal of Translational Medicine. 2021;23:19(1):43. DOI: 10.1186/s12967-021-02706-8. PMID: 33485341.

33. Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, Phan AV, Zolman KL, Peña B, Oweida AJ, Zakem S, Meguid C, Knitz MW, Darragh L, Bickett TE, Gadwa J, Mestroni L, MRG Taylor, Jordan KR, Dempsey P, Lucia SM, McCarter MD, Chiaro MD, Messersmith WA, Schulick RD, Goodman KA, Gough MJ, Greene CS, Costello JC, Neto AG, Lagares D, Hansen KC, Bokhoven AV, Karam SD. Induction of ADAM10 by RT drives fibrosis, resistance, and EMT in pancreatic cancer. Cancer Research. 2021; Epub ahead of print. DOI: 10.1158/0008-5472.CAN-20-3892. PMID: 33526513.

2020

32. Hatmal MM, Alshaer W, Al-Hatamleh MA, Hatmal M, Smadi O, Taha MO, Oweida AJ, Boer JC, Mohamud R, Plebanski M. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. Cells. 2020; 9(12): 2638. https://doi.org/10.3390/cells9122638. PMID: 33302501.

31. Oweida AJ, Mueller AC, Piper M, Milner D, Bhatia S, Phan A, Bickett T, Jordan K, Proia T, Schulick R, Messersmith W, Del Chiaro M, Clambey E, Gough MJ, Williams J, Hansen K, Goodman K, Karam SD. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology, Immunotherapy. 2020; 1-12. https://doi.org/10.1007/s00262-020-02701-w. PMID: 33097963.

30. Bhatia S, Bukkapatnam S, Van Court B, Phan A, Oweida A, Gadwa J, Mueller AC, Piper M, Darragh L, Nguyen D, Gilani A, Knitz M, Bickett T, Green A, Venkataraman S, Vibhakar R, Cittelly D, Karam SD. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Molecular Carcinogenesis. 2020;59(9):1064-1075. https://doi.org/10.1002/mc.23237. PMID: 32567728.

29. AL Hernandez, CD Young, L Bian, K Weigel, K Nolan, B Frederick, G Han, He G, Trahan GD, Rudolph MD, Jones KL, Oweida AJ, Karam SD, Raben D, Wang XJ. PARP inhibition enhances radiotherapy of SMAD4-deficient human head and neck squamous cell carcinomas in experimental models. Clinical Cancer Research. 2020; 26 (12): 3058-3070. DOI: 10.1158/1078-0432.CCR-19-0514. PMID: 32139402.

28. Hararah MK, Stokes WA, Oweida A, Patil T, Amini A, Goddard J, Bowles DW, Karam SD. Epidemiology and treatment trends for primary tracheal squamous cell carcinoma. The Laryngoscope. 2020; 130:405-412. https://doi.org/10.1002/lary.27994. PMID: 30977524.

2019

27. Bravo-Filho V, Logan P, Zoroquiain P, Aldrees S, Vila N, Oweida A, Neto RB, Burnier MN. Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells. Arq Bras Oftalmol. 2019;82(1):38-44. DOI: 10.5935/0004-2749.20190004. PMID: 30403264.

26. Pierce AM, Witt DA, Donson AM, Gilani A, Sanford B, Sill M, Van Court B, Oweida A, Prince EW, Steiner J, Danis E, Dorris K, Hankinson T, Handler MH, Jones KL, Karam SD, Serkova NJ, Vibhakar R, Foreman N, Griesinger AM. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro-oncology. 2019. Epub ahead of print. DOI: 10.1093/neuonc/noz116. PMID:31276586.

25. Hararah MK, Stokes WA, Oweida A, Patil T, Amini A, Goddard J, Bowles D, Karam SD. Epidemiology and Treatment Trends for Primary Tracheal Squamous Cell Carcinoma. The Laryngoscope. 2019. Epub ahead of print. DOI: 10.1002/lary.27994. PMID: 30977524.

24. Darragh L, Oweida A, Karam SD. Overcoming resistance to combination radiation-immunotherapy: a focus on contributing pathways within the tumor microenvironment. Frontiers in Immunology. 2019; 9: 3154. DOI: 10.3389/fimmu.2018.03154. PMID: 30766539.

23. Lennon S, Oweida A, Millner D, Phan A, Bhatia S, Van Court B, Darragh L, Mueller A, Raben D, Torrecuadrada JM, Pitts T, Somerset H, Jordan K, Hansen K, Williams J, Messersmith W, Schulick R, Owens P, Goodman K, Karam SD. Pancreatic tumor microenvironment modulation by EphB4-ephrinB2 inhibition and radiation combination. Clinical Cancer Res. 2019. DOI: 10.1158/1078-0432.CCR-18-2811. PMID: 30944125.

22. Bhatia S, Oweida A, Lennon S, Darragh L, Uyanga N, Bukkapatnam S, Millner D, Phan AV, Van Court B, Gill P, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD. Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers. Cancer Res. 2019. DOI: 10.1158/0008-5472.CAN-18-3257. PMID: 30894369.

21. Oweida A, Bhatia S, Darragh L, Serkova N, Karam SD. Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment. J Vis Exp. 2019; 22: 146. DOI: 10.3791/59195. PMID: 31058896.

20. Oweida A, Darragh L, Phan A, Binder D, Bhatia S, Mueller A, Van Court B, Millner D, Raben D, Woessner R, Heasley L, Nemenoff R, Clambey E, Karam SD. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. J Natl Cancer Inst. 2019; 111(12): 36. DOI: 10.1093/jnci/djz036. PMID: 30863843.

2018

19. Oweida A, Hararah M, Phan A, Binder D, Bhatia S, Lennon S, Milner D, Bukkapatnam S, Van Court B, Uyanga N, Korpela S, Raben D, Tan AC, Heasley L, Clambey E, Nemenoff R, Karam SD. Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration. Clinical Cancer Res. 2018;24 (21):5368-80 . DOI:10.1158/1078-0432.CCR-18-1038. PMID: 30042205.

18. Bhatia S, Sharma S, Bukkapatnam S, Oweida A, Lennon S, Phan AV, Milner D, Uyanga N, Jimeno A, Raben D, Somerset H, Heasley L, Karam SD. Inhibition of EphB4-ephrin-B2 signaling enhances response to Cetuximab-radiation therapy in head and neck cancers. Clinical Cancer Res. 2018;24(18):4539-50. DOI: 10.1158/1078-0432.CCR-18-0327. PMID: 29848571.

17. Hararah MK, Stokes WA, Jones BL, Oweida A, Ding D, McDermott J, Goddard J, Karam SD. Nomogram for Preoperative Prediction of Nodal Extracapsular Extension or Positive Surgical Margins in Oropharyngeal Squamous Cell Carcinoma. Oral Oncology. 2018; 83:73-80. DOI: 10.1016/j.oraloncology.2018.06.005. PMID: 30098782

16. Karam SD, Reddy K, Blatchford PJ, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, Bowles DW, Raben D. Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clinical Cancer Res. 2018;24 (20):4949-59. DOI:10.1158/1078-0432.CCR-18-0467. PMID: 30084837

15. Bhatia S, Griego AM, Lennon S, Oweida A, Sharma J, Rohmer C, Uyanga N, Bukkapatnam S, Vancourt B, Raben D, Young CD, Karam SD. Role of EphB3 receptor in mediating head and neck tumor growth, cell migration, and response to PI3K inhibitor. Mol Cancer Ther. 2018; 17(9)2049-59. DOI: 10.1158/1535-7163.MCT-17-1163. PMID: 29970482.

14. Oweida A, Phan A, Vancourt B, Robin T, Pike L, Mohammad KH, Raben D, Haugen B, Pozdeyev N, Schweppe R, Karam SD. Hypofractionated radiotherapy is superior to conventional fractionation in an orthotopic model of anaplastic thyroid cancer; Thyroid. 2018; 28(6):739-47. DOI:10.1089/thy.2017.0706. PMID: 29774792

13. Oweida A, Sabri S, Al-Rabea A, Ebrahimi M, Ruo R, Fraser R, Seuntjens J, Abdulkarim B. Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer. Oncotarget. 2018; 9:1630-1640. DOI:10.18632/oncotarget.22727. PMID: 29416719

2017

12. Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, Graham C, Binder D, Serkova N, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD.Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma. OncoImmunology. 2017; 6:e1356153. PMID: 29123967

11. Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. J Neuro-oncology. 2017; 132:419-426. PMID: 28374095.

10. Stokes WA, Binder DC, Jones BL, Oweida AJ, Liu AK, Rusthoven CG, Karam SD. Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy. J Neuroimmunology. 2017; 313: 118. DOI: 10.1016/j.jneuroim.2017.10.006. PMID: 29153603

9. Oweida A, Bhatia S, Hirsch K, Keysar S, Pitts T, Jimeno A, Wang XJ, Parkash G, Karam S. Ephrin-B2 Overexpression Predicts for Poor Prognosis and Response to Therapy in Solid Tumors. Mol Carcinogenesis. 2017;56:1189-96. PMID: 27649287. DOI: 10.1002/mc.22574.

8. Summer WA, Stokes WA, Oweida A, Berggren KL, McDermott JD, Raben D, Abbott D, Jones B, Gan G, Karam SD. Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy. J Transl Med. 2017; 15:168. DOI: 10.1186/s12967-017-1268-7.

7. Bhatia S, Hirsch K, Bukkapatnam S, Baig NA, Oweida A, Griego A, Calame D, Sharma J, Donson A, Foreman N, Albanese C, Venkataraman S, Vibhakar R, Karam SD. Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell Int. 2017; 17:41. PMID: 28360821.

6. Stokes B, Bernard J, Bhatia S, Oweida AJ, Bowles D, Raben D, Goddard J, McDermott J, Karam S. A Comparison of Overall Survival for T4 Larynx Cancer between Surgical and Organ-Preservation Approaches, a National Cancer Data Base Analysis. Cancer. 2017; 123:600-608. DOI: 10.1002/cncr.30382. PMID: 27727461.

2016

5. Bhatia S, Hirsch K, Sharma J, Oweida A, Keysar S, Jimeno A, Wang XJ, Karam S. Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas. Sci Reports. December 2016. DOI: 10.1038/srep38792. PMID: 27941840.

4. Oweida A, Sharifi Z, Halabi H, Xu Y, Sabri S, Abdulkarim B. Differential Response to Ablative Ionizing Radiation in Genetically Distinct Non-Small Cell Lung Cancer Cells. Canc Biol Ther. 2016; 17:390-9. PMID: 27096542.

3. Oweida A and Abdulkarim B. Ablative versus Fractionated Radiation Therapy: A Controversial Role in Cancer Invasion and Metastasis. Oncogene. 2016; 35: 5928. DOI:10.1038/onc.2016.130. PMID: 27109097.

2007

2. Oweida AJ, Dunn E, Dekaban GA, Karlik SJ, Foster PJ. Iron Oxide Labelling of Hematogenous Macrophages in a Model of Experimental Autoimmune Encephalomyelitis and the Contribution to Signal Loss in FIESTA Images. J Magn Reson Imag. 2007; 26:144-51. PMID: 17659552.

2004

1. Oweida AJ, Dunn E, Foster PJ. Cellular Imaging at 1.5T: Detecting Cells in Neuroinflammation Using Active Labelling with Superparamagnetic Iron Oxide. Molecular Imaging. 2004; 3:85-95. PMID: 15296673.

Published Abstracts – Refereed

24) Oweida AJ, Hararah M, Phan A, Bhatia S, Lennon S, Binder D, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation in anti-PD-L1 refractory head and neck cancer. American Association for Cancer Research Annual Conference. April 2018. Chicago, IL.

23) Oweida AJ, Phan A, Vancourt B, Robin T, Raben D, Haugen B, Pozdeyev N, Schweppe R, Karam SD. Radioresistant anaplastic thyroid cancers display a unique gene signature and respond to hypofractionated radiotherapy. American Association for Cancer Research Annual Conference. April 2018. Chicago, IL.

22) Oweida AJ, Calame D, Lennon S, Bhatia S, Raben D, Clambey E, Heasley L, Nemenoff R, Karam SD. Radiotherapy Sensitizes Head and Neck Tumors to PD-L1 Immune Checkpoint Blockade. American Society for Radiation Oncology, ASTRO's 59th Annual Meeting. September 2017. San Diego, CA.

21) Oweida A, Calame D, Lennon S, Bhatia S, Sharma J, Caleb G, Raben D, Heasley L, Clambey E, Nemenoff E, Karam SD. Radiotherapy enhances T-cell infiltration and efficacy of PD-L1 blockade in murine orthotopic models of head and neck cancer. American Society for Clinical Oncology and Society for Immunotherapy Conference. Orlando, FL. February 2017.

20) Oweida A, Sharifi Z, Ebrahimi M, Fraser R, Sabri S, Ruo R, Seuntjens J, Abdulkarim B. Differential Cellular and Molecular Response to Ablative Radiation in Non-Small Cell Lung Cancer Based on Molecular Subtype. World Conference on Lung Cancer. Denver, CO. September 2015.

19. Oweida A, Sharifi Z, Xu Y, Sabri S, Abdulkarim B. Evolving biological and clinical concepts of radiation delivery in NSCLC: response to ablative versus fractionated radiotherapy. American Association for Cancer Research Annual Conference. San Diego, CA. April 2014.

18. Oweida A, Sharifi Z, Xu Y, Sabri S, Abdulkarim B. Ablative radiotherapy increases invasion potential in EGFR-wildtype nonsmall cell lung cancer cells compared to fractionated radiotherapy. Molecular Targets and Cancer Therapeutics International Conference. American Association for Cancer Research. Boston, MA. October 2013.

17. Oweida AJ, Xu Y, Sabri S, Abdulkarim B. The Biological and Cellular Response of Non-Small Cell Lung Cancer Cell Lines to Radiation Therapy Based on EGFR Status. Cancer Axis Symposium. McGill University Health Centre. Montreal. June 2013.

16. Oweida A, Xu Y, Sabri S, Abdulkarim B. Unraveling the biological basis for improved tumor control in single-dose irradiation compared to fractionated irradiation in non-small cell lung cancer. Annual McGill Biomedical Graduate Conference. Montreal. February 2013.

15. Townson JL, Libby K, MacKenzie LM, Oweida AJ, Leckie A, Foster PJ, MacDonald IC, Sporn MB, Chambers AF. The synthetic triterpendoid CDDO-Im decreases experimental liver metastasis tumor burden in vivo. Molecular Targets and Cancer Therapeutics. San Francisco, CA, USA. 2007.

14. Oweida A, MacKenzie L, Townson J, Chambers A, Rutt B, Foster P. In vivo cell detection by MRI using Feridex-labeled cells. AMI/SMI Joint Conference. Providence, USA. 2007.

13. Oweida A, Ramadan S, MacKenzie LT, Chambers A, Rutt BK, Foster P. Tracking the fate of iron labeled metastatic cancer cells in mouse brain. AMI/SMI Joint Conference. Providence, USA. 2007.

12. Oweida A, Ramadan S, MacKenzie L, Chambers A, Rutt B, Foster PJ. The need to image living cells using MRI. Imaging Network of Ontario. Toronto. 2007.

11. Oweida A, Dunn E, Foster P. In vivo detection and monitoring of inflammatory lesions in experimental autoimmune encephalomyelitis using SPIO-enhanced MRI. European Committee for the Treatment and Research in Multiple Sclerosis. Madrid, Spain. 2006.

10. Oweida AJ, Dekaban GA, Karlik SJ, Foster PJ. The Lys-EGFP-ki Transgenic Mice: A Model for Imaging Immune Cells in EAE. Imaging Network of Ontario. Toronto. 2006.

9. Oweida AJ, Dekaban GA, Karlik SJ, Foster PJ. The Lys-EGFP-ki Transgenic Mice: A Model for Imaging Immune Cells in EAE. Poster presentation. Myelin Imaging Meeting. Vancouver. 2006.

8. Oweida A, Dunn E, Foster P. Cellular Imaging of Neuro-inflammation: A Novel Method for Unraveling the Roles of Macrophage Populations in EAE. Poster presentation. International Society for Magnetic Resonance in Medicine (ISMRM) 13th annual conference. Miami, USA. 2005.

7. Oweida A, Dunn E, Dekaban G, Foster P. The lys-EGFP-ki Transgenic Mouse: A Novel Model System for Studying the Cells Involved in Neuro-inflammation in EAE. Oral presentation. ISMRM 13th annual conference. Miami, USA. 2005.

6. Oweida AJ, Dunn EA, Dekaban GA, Foster PJ. In vivo Cellular Imaging of Macrophage Activity in Neuro-inflammation. Poster presentation. Imaging Network of Ontario 4th symposium. Toronto 2005.

5. Oweida AJ, Dunn E, Dekaban GA, Foster PJ. In vivo Cellular Imaging of Neuro-inflammation in an Animal Model for Multiple Sclerosis. Oral presentation. Western Research Forum. London, ON. 2005.

4. Oweida A, Dunn E, Foster P. Imaging the Cellular Inflammatory Response in Experimental Allergic Encephalomyelitis using 3DFIESTA at 1.5T. Oral presentation. ISMRM 12th Annual Conference. Kyoto, Japan. 2004.

3. Oweida AJ, Dunn E, Foster PJ. Cellular Imaging of Inflammation Using a 1.5 T Clinical MRI Scanner. Poster presentation. Imaging Network of Ontario 3rd Symposium. Toronto. 2004.

2. Oweida AJ, Dunn E, Foster P. Imaging Inflammation in EAE. Poster presentation for the Margaret Moffat Research Symposium. University of Western Ontario. London, ON. 2004.

1. Foster P, Heyn C, Dunn, Oweida A, Alejski A, Rutt BK. Imaging Cells in Neuro-Inflammation. Poster presentation. Society for Molecular Imaging (SMI) conference. San Diego, USA. 2003.

Invited Presentations

20. Considerations in the adoption of immunotherapy for head and neck cancer patients. Department of Head and Neck Surgery Grand Rounds (Accredited CME Learning Session). McGill University. March 29, 2018.

19. Synergy of radiotherapy and immunotherapy in head and neck cancer. Cancer Research Seminar. McGill University. Montreal, QC. March 29, 2018.

18. Hypofractionated radiotherapy is superior to conventional radiotherapy in orthotopic mouse models of anaplastic thyroid cancer. Radiation Interest Group. University of Colorado Denver – Anschutz medical campus. Denver, CO. January 4, 2018.

17. Animal Imaging Science Workshop – Nuts and Bolts. Department of Radiology. University of Colorado Denver – Anschutz medical campus. Denver, CO. January 3, 2018.

16. Precision radiotherapy and image-guided tracking. Cancer Center Seminar. University of Colorado Denver – Anschutz medical campus. Denver, CO. May 4, 2017.

15. Radiation-induced type I interferon signaling in lung cancer. Department of Radiation Oncology. University of Colorado Denver – Anschutz medical campus. Denver, CO. April 13, 2017.

14. Mechanisms of synergy between immunotherapy and radiotherapy. Department of Nuclear Medicine and Radiobiology. Sherbrooke University. Sherbrooke, QC. April 10, 2017.

13. Transforming the immune landscape with radiation therapy in head and neck cancer. Lung and Head and Neck Cancer Program. University of Colorado – Anschutz medical campus. Denver, CO. March 9, 2017.

12. Unraveling the Biological Basis for Ablative Radiotherapy in Non-Small Cell Lung Cancer. Department of Medical Physics. Montreal General Hospital. Montreal. June 2013.

11. Imaging Hypoxia and the Impact on Radiotherapy Treatment Planning. Department of Medical Physics Gradate Seminars. Montreal General Hospital. Montreal. February 2010.

10. The need to image living cells using MRI. Imaging Network of Ontario Conference. Toronto. 2007.

9. Magnetic Resonance Imaging of Macrophage Activity in Multiple Sclerosis using Iron Oxide Nano-Particles. Montreal Neurological Institute, McGill University. Montreal, Canada. June 2006.

8. The Lys-EGFP-ki Transgenic Mice: A Model for Imaging Immune Cells in EAE. Imaging Network of Ontario. Toronto, ON. April 2006.

7. Cellular Imaging of Immune Cells in an Animal Model for Multiple Sclerosis. Department seminar. University of Western Ontario. London, ON. March 2006.

6. Cellular Imaging in Multiple Sclerosis. Cellular imaging inaugural retreat. University of Western Ontario. London, ON. June 2005.

5. In vivo Cellular Imaging of Neuroinflammation in an Model for Multiple Sclerosis. University of Western Ontario Research Forum. London, ON. April 2005.

4. Unravelling the Roles of Macrohpage Populations in an Animal Model for Multiple Sclerosis. Department seminar. University of Western Ontario. London, ON. April 2005.

3. Cellular Imaging of Neuroinflammation: Novel Methods for Unravelling Biological Mechanisms. Presentation for the Spinal Cord Injury Team and the Imaging Group at the Robarts Research Institute. London, ON. November 2004.

2. Imaging Inflammation in an Animal Model for Multiple Sclerosis. Public presentation for the biophysics 480 thesis course. University of Western Ontario. London, ON. April 2004.

1. Micro-Imaging of the Cellular Inflammatory Response at 1.5T. Presentation for the Imaging, Immunology, and Bio-therapeutics groups at the Robarts Research Institute. London, ON. February 2004.

Published Educational Papers

11. AIDS in Africa: An Overview. By: Oweida, Ayman. Canadian Points of View: AIDS in Africa, 2009, p1-1, 1p; Reading Level (Lexile): 1290; (AN 44716243).

10. Counterpoint: The Minimum Driving Age Should be Raised in Order to Reduce Traffic Accidents. By: Oweida, Ayman. Canadian Points of View: Minimum Driving Age, 2009, p3-3, 1p; Reading Level (Lexile): 1320; (AN 44649649).

9. In Vitro Fertilization: An Overview. By: Oweida, Ayman. Canadian Points of View: In Vitro Fertilization, 2009, p1-1, 1p; Reading Level (Lexile): 1290; (AN 44647092).

8. Point: Prenatal Testing Ensures the Birth of Healthy Infants. By: Oweida, Ayman. Canadian Points of View: Prenatal Testing for Disabilities, 2009, p2-2, 1p; Reading Level (Lexile): 1420; (AN 44745208)

7. Animal Rights: An Overview. Canadian Points of View. EBSCO Publishing Inc. 2010. (Co-Author).

6. Cloning: An Overview. Canadian Points of View. EBSCO Publishing Inc. 2010. (Co-Author).

5. Genetically Modified Food: An Overview. Canadian Points of View. EBSCO Publishing Inc. 2010. (Co-Author).

4. Wikipedia is a Valuable Tool. Canadian Points of View. EBSCO Publishing Inc. 2010. (Co-Author).

3. Stem Cell Research: An Overview. Canadian Points of View Project. EBSCO Publishing Inc. 2010. (Co-Author).

2. Introduction to Computed Tomography. Applied Science Project. EBSCO Publishing Inc. 2009.

1. Introduction to Radiology and Medical Imaging. Applied Science Project. EBSCO Publishing Inc. 2009.

Translated Documents

19. Testing for Tuberculosis: Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

18. Tuberculosis. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

17. Preventing Infections in Hospitals. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

16. Methicillin-Resistant Staphylococcus Aureus (MRSA). Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

15. Vancomycin-Resistant Enterococcus (VRE). Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

14. Chlamydia. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

13. Gonorrhea. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

12. Herpes Simplex Virus (HPV) and Men. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

11. Herpes Simplex Virus (HPV) and Women. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

10. Syphilis. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

9. Scabies. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

8. Candida Yeast Infections. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

7. Infectious Diseases Clinic: Patient Information Sheet. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

6. Viral Gastroenteritis. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

5. Clostridium Difficile Infection. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

4. Hepatitis A. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

3. Hepatitis B. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

2. Hepatitis C. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].

1. Hand Washing. Patient Information Sheet. Jewish General Hospital. Montreal, Canada. 2008. [English to Arabic].